TY - JOUR
T1 - MIN6 cells-enclosing aminopropyl-silicate membrane templated by alginate gels differences in guluronic acid content
AU - Sakai, Shinji
AU - Ono, Tsutomu
AU - Ijima, Hiroyuki
AU - Kawakami, Koei
N1 - Funding Information:
We thank Prof. Miyazaki and Dr. Yamato (Osaka University, Japan) for provision and technical advices for treating of MIN6 cell. This work was supported by grant from JSPS Research Fellowships for Young Scientists. This financial support is greatly appreciated.
PY - 2004/2/11
Y1 - 2004/2/11
N2 - Mouse insulinoma (MIN6) cells were encapsulated into aminopropyl-silicate membrane deposited on calcium alginate gel beads via the sol-gel synthesis. Two alginates with different guluronic acid (G) contents, high and intermediate, but with the same molecular weights were used. Viability of the cells in the membrane templated by the alginate with an intermediate content of guluronic acid (intermediate-G) was approximately 10% higher than those in the membrane templated by the alginate with a high content of guluronic acid immediately after encapsulation. Growth of cells in vitro was hindered in case of encapsulation in the aminopropyl-silicate membrane deposited on the high-G alginate gel. The MIN6 cells in the microcapsule made from high-G alginate needed a longer period to establish a normoglycemic in recipients than those in the microcapsule made from intermediate-G alginate despite the same number of viable cells implantation. Recipients of the microcapsule with the core made from the intermediate-G alginate maintained their blood glucose values less than 300mg/dl for a longer period.
AB - Mouse insulinoma (MIN6) cells were encapsulated into aminopropyl-silicate membrane deposited on calcium alginate gel beads via the sol-gel synthesis. Two alginates with different guluronic acid (G) contents, high and intermediate, but with the same molecular weights were used. Viability of the cells in the membrane templated by the alginate with an intermediate content of guluronic acid (intermediate-G) was approximately 10% higher than those in the membrane templated by the alginate with a high content of guluronic acid immediately after encapsulation. Growth of cells in vitro was hindered in case of encapsulation in the aminopropyl-silicate membrane deposited on the high-G alginate gel. The MIN6 cells in the microcapsule made from high-G alginate needed a longer period to establish a normoglycemic in recipients than those in the microcapsule made from intermediate-G alginate despite the same number of viable cells implantation. Recipients of the microcapsule with the core made from the intermediate-G alginate maintained their blood glucose values less than 300mg/dl for a longer period.
UR - http://www.scopus.com/inward/record.url?scp=0347022246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347022246&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2003.10.014
DO - 10.1016/j.ijpharm.2003.10.014
M3 - Article
C2 - 14726123
AN - SCOPUS:0347022246
SN - 0378-5173
VL - 270
SP - 65
EP - 73
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1-2
ER -